Status:
COMPLETED
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.
Detailed Description
we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19. As, zinc may be of value in these cases and may be of value in enhancing chloroqui...
Eligibility Criteria
Inclusion
- Patients with positive COVID-19.
Exclusion
- Contraindications or hypersensitivity to chloroquine.
Key Trial Info
Start Date :
June 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2020
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT04447534
Start Date
June 23 2020
End Date
August 15 2020
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta university hospital, Assuit University, Ainshams University
Tanta, Egypt